SlideShare a Scribd company logo
1 of 4
Download to read offline
1
Transmission & Distribution
Skipper Ltd.
Sensex: 26425 CMP:INR153
Leading player in the transmission tower business
Skipper is among the top 3 players in the transmission tower
business (after KEC Intl and Kalpataru) with a capacity of 175000
MTPA (25000 added in H1CY15). The company operates in 400
KV - 1200 KV segment, which has entry barriers like pre-
qualification, quality & infrastructure related criteria, and
derives 85% of revenue from Powergrid projects. 54% of India's
transmission line network is expected to be in 400 KV and above
by the end of 12th Plan.
Presence across transmission business sub-segments
The transmission business also consist of poles-monopoles
segment and galvanising facilities. Monopoles find their
application in telecom towers and replacement of lattice towers
in urban areas. Telecom companies, PGCIL and SEBs are now
prefering use of monopoles for their urban and semi-urban
regions. The company also has galvanising capacity of ~150000
MTPA for galvanising towers and poles. Skipper is planning to
further expand the galvanising capacity by 50000 MTPA.
10x increase in PVC pipes capacity
Skipper plans to increase the PVC pipe (7% of revenue) capacity
by 10x to 100000 MTPA by FY18 of which 30000 MTPA is likely to
start in FY16 (10000 each in Ahmedabad, Secunderabad and
Guwahati; Ahmedabad facility started). Multi-locational
manufacturing facilities will help in saving freight costs and aid
margin expansion. With multifold increase in capacity and decent
profit margin, we expect PVC division to contribute significantly
to the overall revenue & profits. To increase the share of revenue
from plumbing sector, the company has partnered with global
leaders like Sekisui Chemicals (Japan) and Wavin group
(Netherlands) for CPVC and fittings respectively. Currently agri
June 15, 2015 VISITNOTE
sector account for 75% of revenue, which the company is planning
toreduceto60%inthecomingquarters.Thecompanyhasamarket
share of ~10% in Eastern India.
Integrated Business model
Skipper claims to be the only integrated player of its size in India.
Angle rolling, which is the main raw material for towers, is
manufactured inhouse (capacity- 180000 MTPA). Skipper also
enjoys the locational advantage of being situated in Eastern India
where all the primary steel plants are located, thereby saving
logistics cost for the company on raw materials. Skipper has also
done forward integration and now participates in EPC projects.
Capex plans & Debt outlook
The company plans to incur capex of INR 350 mn in FY16 of which
INR 200 mn will be invested in PVC pipe division capex and INR
150 mn for transmission business. The company has total
outstanding debt of ~INR 4 bn including CC of INR 2 bn. Given its
sizeable capex requirements over the medium term, we don't
expect significant reduction in debt going forward.
Order book
The company has order book of ~INR 24 bn (Book to bill ratio of
1.83x) of which 45% is from overseas and rest is domestic. Most
of the export orders are from LATAM.
Outlook and Valuation
The Power ministry plans to attract investments worth INR 4000 bn
in the T&D space over the next 4 years. Creation of smart cities,
focus on improving irrigation facilities, rapid urbanisation and
improvement in urban infrastructure are likely to create demand
for water transportation pipes. Skipper ltd. is gearing up to cash in
ontheemergingopportunitieswithaggressivecapexandincreasing
distribution reach (coupled with brand led marketing). Topline &
bottomlinegrewataCAGRof20.8%and118.3%respectivelybetween
FY13-15. At CMP, the stock is trading at 17.5x FY15 earnings.
Shareholding (%) Mar-15
Promoters 72.38
FIIs 0.16
DIIs 0.00
Others 27.46
Relative Price Performance
Key Data
BSE Code 538562
NSE Code SKIPPER
Bloomberg Code SKIPPER IN
Shares Outstanding (mn) 102.32
Face Value 1
Mcap (INR bn) 16.16
52 Week H/L 200.00/32.00
2W Avg. Qty.NSE 5533
Free Float (INR Bn) 4.46
Beta 1.21
(INR mn) FY12 FY13 FY14 FY15
Net Sales 7629 9282 10731 13128
Growth 47.20% 21.67% 15.61% 22.34%
EBIDTAM (%) 8.17 9.73 11.01 16.39
Adj. PAT 98 187 269 892
Growth -40.33% 91.51% 43.67% 231.36%
Adj. EPS (INR) 0.96 1.81 2.6 8.72
P/E(x) NA NA NA 17.55
EV/EBIDTA NA NA NA 8.86
Net Debt/Equity 1.78 2 1.79 1.08
RoACE (%) 10.7 14.56 16.24 17.52
RoAE (%) 5.94 11.24 12.53 27.88
At our recent interaction with the management of Skipper limited, they sounded positive on the road ahead on the back of
significant emerging opportunities in the power transmission tower sector and PVC pipes industry. Skipper limited, promoted
by Kolkata based Bansal group, is engaged in manufacturing of towers (power transmission and telecom), PVC pipes &
fittings, poles & monopoles, etc. Transmission segment, PVC pipes segment and Infrastructure segment account for 89%,
7% and 4% of revenues respectively. The company aspires to grow in Power T&D business by 3x and Water business by 10x.
Given below are the key takeaways from the visit-
Prashant Biyani
prashant.biyani@spagroupindia.com
Ph. No. 91 33 4011 4800 (Ext. 833)
0
100
200
300
400
500
600
Jul-14
Aug-14
Sep-14
Oct-14
Nov-14
Dec-14
Jan-15
Feb-15
Mar-15
Apr-15
May-15
Jun-15
Skipper Sensex
2
Transmission & Distribution
Quarterly Financials
Particulars (INR Mn) Q4FY15 Q3FY15 QoQ Q2FY15 Q1FY15 Q4FY14 YoY
Gross Sales 5601 3537 58.37% 3378 2056 4730 18.44%
Excise Duty 602 309 94.57% 309 224 416 44.57%
Net Sales 4999 3227 54.90% 3069 1832 4313 15.91%
Other Income 1 7 -88.41% 1 8 9 -90.91%
Total Income 5000 3234 54.60% 3070 1840 4322 15.69%
Raw Material Consumed 2489 2508 -0.75% 1853 1700 2778 -10.39%
Stock Adjustment 1128 (276) NA (71) (535) 715 57.84%
Employee Expenses 87 93 -6.24% 89 71 70 24.04%
Other Expenses 608 427 42.28% 481 321 373 62.99%
TOTAL EXPENDITURE 4313 2753 56.64% 2352 1558 3936 9.57%
EBITDA 687 474 44.85% 717 274 377 82.10%
Depreciation 63 52 22.63% 51 54 38 67.72%
EBIT 624 422 47.57% 666 220 339 83.71%
Interest 154 173 -11.37% 129 127 201 -23.70%
PBT 471 256 83.80% 538 101 147 220.42%
Tax 168 86 96.73% 185 35 39 333.51%
PAT 303 171 77.32% 353 65 108 179.83%
Equity 102 102 0.00% 102 102 102 0.00%
Face Value 1 1 0.00% 1 1 1 0.00%
EPS 2.96 1.67 77.32% 3.45 0.64 1.06 179.83%
EBITDAM 13.74% 14.69% (95 bps) 23.35% 14.95% 8.75% 499 bps
OPM 13.76% 14.91% (115 bps) 23.38% 15.38% 8.95% 481 bps
PATM 6.05% 5.29% 76 bps 11.50% 3.57% 2.51% 354 bps
Segmental Quarterly Financials
Particulars (INR Mn) Q4FY15 Q3FY15 QoQ Q2FY15 Q1FY15 Q4FY15 YoY
REVENUES
Infrastructure Projects 152 141 8.09% 110 59 162 -6.16%
PVC Pipe 434 187 131.45% 93 184 273 58.85%
Engineering Products 4413 2899 52.23% 2446 1589 3878 13.81%
Profit/Loss Before Interest and Tax
Infrastructure Projects 13 53 -76.33% 28 16 79 -84.24%
PVC Pipe 55 19 195.72% 18 11 21 160.85%
Engineering Products 970 390 148.55% 233 217 273 255.69%
CAPITAL EMPLOYED
Infrastructure Projects 189 196 -3.47% 205 186 163 16.14%
PVC Pipe 459 301 52.22% 294 297 334 37.40%
Engineering Products 6218 7289 -14.70% 7179 5827 5836 6.53%
3
Transmission & Distribution
Financials
Income statement
Year End March (INR mn) FY12 FY13 FY14 FY15
Net Sales 7629 9282 10731 13128
Growth 47.20% 21.67% 15.61% 22.34%
Cost of Goods Sold 5582 6829 7601 8797
Employee Cost 154 173 242 341
Other Optg. Exps. 1270 1377 1707 1838
Total Optg. Exps. 7006 8378 9549 10976
EBIDTA (excl OI) 623 903 1182 2152
Growth 26.99% 45.03% 30.81% 82.08%
EBITDA Margin 8.17% 9.73% 11.01% 16.39%
Dep./Amortization 117 126 151 220
EBIT 506 778 1031 1932
EBIT Margin 6.63% 8.38% 9.61% 14.71%
Interest Expense 368 514 685 583
Other Income 8 14 21 17
EBT 146 278 367 1366
Tax Expenses 47 91 98 474
PAT 99 187 269 892
Adjustment to PAT 1 (0) 0 0
APAT 98 187 269 892
Growth -40.33% 91.51% 43.67% 231.36%
APAT Margin 1.28% 2.02% 2.51% 6.79%
Balance Sheet
Year End March (INR mn) FY12 FY13 FY14 FY15
Share Capital 360 97 102 102
Reserves and Surplus 1275 1964 2209 3096
Total Networth 1635 2061 2312 3199
Total Debt 2994 4243 4395 4000
Deferred Tax Liability 111 181 218 265
Other Liabilities 7 16 10 0
Sources of Funds 4709 6462 6896 7463
Net Block 2809 3259 3430 3547
Investments 0 0 0 0
Current Assets 3839 4562 5326 7059
Current Liabilities 1946 1368 1881 3173
Net Current Assets 1892 3194 3445 3886
Other Assets 7 9 21 30
Application of Funds 4709 6462 6896 7463
Cash Flow
Year End March (INR mn) FY12 FY13 FY14 FY15
EBT 146 278 367 1366
Less: Other Income/Exceptionals (8) (14) (21) (17)
Add:Depreciation 117 126 151 220
Add: Interest paid 368 514 685 583
Direct taxes paid (29) (56) (77) (474)
Change in Working Capital 846 (1260) (116) (589)
Others 16 28 43 0
Cash Flow from operations (a) 1456 (383) 1032 1089
Change in Fixed Assets (548) (574) (315) (118)
Change in Investments 0 0 0 0
Cash Flow from Investing (b) (548) (574) (315) (118)
Change in Equity 0 540 0 0
Debt Raised/(Repaid) (477) 1249 152 (395)
Interest paid (368) (514) (685) (583)
Others (7) (10) (15) 422
Cash Flow from Financing (c ) (852) 1265 (549) (673)
Net Change in Cash (a+b+c) 57 308 168 298
Opening Cash 69 86 128 263
Closing Cash 86 128 263 561
Key Ratios
Year End March FY12 FY13 FY14 FY15
Per Share Data (INR)
Reported EPS 1.40 1.92 2.63 8.72
Adj. EPS 1.34 1.83 2.63 8.72
Growth -43.93% 36.57% 43.72% 231.43%
CEPS 2.92 3.06 4.10 10.87
DPS 0.09 0.09 0.15 1.30
BVPS 17.66 19.76 22.22 31.27
Return Ratios (%)
RoACE 10.70 14.56 16.24 17.52
RoANW 5.94 11.24 12.53 27.88
Liquidity Ratios
Net Debt/Equity 1.78 2.00 1.79 1.08
Interest Coverage Ratio 1.40 1.54 1.54 0.30
Current Ratio 1.97 3.34 2.83 2.22
Efficiency Ratios
Asset Turnover Ratio 1.62 1.44 1.56 1.76
Inventory Days 75 103 108 98
Debtor Days 64 56 73 84
Creditor Days 50 61 66 83
Valuation Ratios
P/E(x) NA NA NA 17.55
P/BV (x) NA NA NA 4.89
P/CEPS (x) NA NA NA 14.08
Dividend Yield (%) NA NA NA 0.85
EV/Net Sales (x) NA NA NA 1.45
EV/EBIDTA(x) NA NA NA 8.86
4
Transmission & Distribution
For More Information Visit Us At : www.spasecurities.com
Sharad Avasthi Head - Equity Research sharad.avasthi@spagroupindia.com Tel.: +91-33-4011 4800 Ext.832
SPA Securities Ltd: Mittal Court, A-Wing, 10th Floor, Nariman Point, Mumbai - 400 021, Tel. No. : +91-022-4289 5600, Fax: +91 (22) 2657 3708/9
Analyst Certification of Independence: The analyst(s) for this report certifies that all the views expressed in this report accurately reflect his or her personal views about the subject company(ies) or issuers and no part of his or
hercompensationwas,isorwillbe,directlyorindirectlyrelatedtospecificrecommendationsorviewsexpressedinthisreport.Theresearchanalystsareboundbystringentinternalregulationsandalsolegalandstatutoryrequirements
of the Securities and Exchange Board of India (hereinafter "SEBI") and the analysts' compensation are completely delinked from all the other companies and/or entities of SPASecurities Limited, and have no bearing whatsoever on
anyrecommendationthattheyhavegivenintheResearchReport.
DisclaimerandDisclosuresasrequiredunderSEBI(Research Analyst)Regulations,2014:SPASecuritiesLimited(hereinafterreferasSPASecurities)anditsaffiliatesareengagedininvestmentbanking,investment advisory,
stock broking, institutional equities, Mutual Fund Distributor and insurance broking. SPASecurities is a SEBI registered securities broking Company having membership of NSE, BSE & MCX for Equity, Future & Option, Currency
Derivatives segment and Wholesale Debt Market. The Company is focused primarily on providing securities broking services to institutional clients and is empanelled as an approved securities broker with all the major Nationalised,
PrivateandCo-operativebanks,Corporatehouses,InsuranceCompanies,FinancialInstitutions,AssetManagementCompaniesandProvidentFundTrusts.Detailsofaffiliatesareavailableonourwebsitei.e.www.spasecurities.com.
Weherebydeclarethatouractivitieswereneithersuspendednorwehavedefaultedwithanystockexchangeauthoritywithwhom weareregisteredinthelastfiveyears.WehavenotbeendebarredfromdoingbusinessbyanyStock
Exchange/SEBI or any other authorities, nor has our certificate of registration been cancelled by SEBI at any point of time.
GeneralDisclosures: ThisResearchReport(hereinaftercalled"report")hasbeenpreparedbySPASecuritiesandismeantforsoleusebytherecipientandnotforcirculation.ThisReportdoesnotconstituteapersonalrecommendation
or take into account the particular investment objectives, financial situations, or needs of individual clients. The recommendations, if any, made herein are expression of views and/or opinions and should not be deemed or construed
tobeneitheradviceforthepurposeofpurchaseorsaleofanysecurity,(asdefinedundersection2(h)ofsecuritiesContracts(Regulation)Act.1956,throughSPASecuritiesnoranysolicitationorofferingofanyinvestment/tradingopportunity
onbehalfoftheissuer(s)oftherespectivesecurity(ies)referredtoherein.RecipientsofthisReportshouldrelyoninformation/dataarisingoutoftheirowninvestigations.Readersareadvisedtoseekindependentprofessionaladvice
and arrive at an informed trading/investment decision before executing any trades or making any investments.
ThisReporthasbeenpreparedonthebasisofpubliclyavailableinformation,internallydevelopeddataandothersourcesbelievedbySPASecuritiestobereliable,althoughitsaccuracyandcompletenesscannotbeguaranteed.Such
information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness.Any review, retransmission or any other use is prohibited.
The information, opinions, views expressed in this Research Report are those of the research analyst as at the date of this Research Report which are subject to change and do not represent to be an authority on the subject. While
we would endeavour to update the information herein on a reasonable basis, we are under no obligation to update the information.Also, there may be regulatory, compliance or other reasons that prevent us from doing so. Hence all
such information and opinions are subject to change without notice.
Our salespeople, traders, and other professionals may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading
and investing businesses may make investment decisions that may be inconsistent with the recommendations expressed herein.
This Research Report should be read and relied upon at the sole discretion and risk of the recipient. If you are dissatisfied with the contents of this complimentary Research Report or with the terms of this Disclaimer, your sole and
exclusive remedy is to stop using this Research Report. Neither SPASecurities nor its affiliates or their respective directors, employees, agents or representatives shall be responsible or liable in any manner, directly or indirectly, for
the losses or the damages sustained due to the investments made or any action taken on basis of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in
the NAVs, reduction in the dividend or income, etc.
Compensation of our ResearchAnalysts is not based on any specific merchant banking, investment banking or brokerage service transactions. SPASecurities may have issued other reports in the past that are inconsistent with and
reachdifferentconclusionfromtheinformationpresentedinthisreport.
SPASecurities, its affiliates and employees may, from time to time, effect or have effected an own account transaction in, or deal as principal or agent in or for the securities mentioned in this document.They may perform or seek to
perform investment banking or other services for, or solicit investment banking or other business from, any company referred to in this report.
TheusershouldconsulttheirownadvisorstodeterminethemeritsandrisksofinvestmentandalsoreadtheRiskDisclosureDocumentsforCapitalMarketsandDerivativeSegmentsasprescribedbySecuritiesandExchangeBoard
of India before investing in the Indian Markets.
A graph of daily closing prices of securities is available at www.nseindia.com and http://economictimes.indiatimes.com/markets/stocks/stock-quotes. (Choose a company from the list on the browser and select the "three years" icon
in the price chart).
SPASecurities plans to register itself as a Research Entity under the SEBI (ResearchAnalysts) Regulations, 2014.
Disclaimers in respect of jurisdiction: This report is not directed to, or intended for distribution to or use by, any person or entity who is a citizen or resident or located in any locality, state, country or other jurisdiction where such
distribution, publication, reproduction, availability or use would be contrary to law or regulation or what would subject SPASecurities or its affiliates to any registration or licensing requirement within such jurisdiction. If this report is
inadvertentlysendorhasreachedanyindividualinsuchcountry,especially,USA,thesamemaybeignoredandbroughttotheattentionofthesender.Thisdocumentmaynotbereproduced,distributedorpublishedforanypurposes
without prior written approval of SPASecurities.
List of Associates as per SEBI (Research Analyst) Regulations, 2014
• SPAInsurance Broking Services limited
Statements on ownership and material conflicts of interest, compensation - SPA and Associates
Disclosure of interest statement Yes/No
SPA Securities/its Affiliates/Analyst/his or her Relative financial interest in the company No
SPA Securities/its Affiliates/Analyst/his or her Relative actual/beneficial ownership of more than 1% in subject company at the end of the month
Immediately preceding the date of the publication of the research report or date of public appearance. No
Investment banking relationship with the company covered No
Any other material conflict of interest at the time of publishing the research report No
Receipt of compensation by SPA Securities or its Affiliated Companies from the subject company covered for in the last twelve months:
• Managing/co-managing public offering of securities
• Investmentbanking/merchantbanking/brokerageservices
• products or services other than those above
• in connection with research report
No
Whether Research Analyst has served as an officer, director or employee of the subject company covered No
Whether the Research Analyst or Research Entity has been engaged in market making activity of the Subject Company; No
For statements on ownership and material conflicts of interest, compensation, etc. for individual Research Analyst(s), please refer to each specific research report.
SPA CAPITAL SERVICES LIMITED
Investment Advisory Services,
AMFI Reg. No. ARN-0007
SPA CAPITAL ADVISORS LIMITED
SEBI registered Category-1
Merchant Bankers
SEBI Regn. No. INM000010825
SPA COMTRADE PRIVATE LIMITED
Member of NCDEX & MCX.
NCDEX TMID-00729,
NCDEXFMCNo.NCDEX/TCM/CORP/0714
SPAINSURANCE BROKING SERVICES LTD
Direct Broker for Life and General
Insurance Broking
IRDA Lic. Code No. DB053/03
SPA Securities Ltd SEBI Reg. Nos.
NSE Cash INB231178238
NSE Future & Option INF231173238
NSE Currency Derivatives INE231178238
BSE Cash INB011178234
BSE Currency Derivatives INE011178234
MCX-SX Cash INB261178231
MCX-SX Future & Option INF261178231
MCX-SX Currency Derivatives INE261178238
Mutual Fund ARN 77388
CDSLDP IN-DP-CDSL-485-2008
NSDLDP IN-DP-NSDL-316-2009

More Related Content

What's hot

Firstcall gillette 01jun15[1]
Firstcall gillette 01jun15[1]Firstcall gillette 01jun15[1]
Firstcall gillette 01jun15[1]IndiaNotes.com
 
Medium-Long term investment: Buy NIIT for target price of 408
Medium-Long term investment: Buy NIIT for target price of 408Medium-Long term investment: Buy NIIT for target price of 408
Medium-Long term investment: Buy NIIT for target price of 408IndiaNotes.com
 
Q4FY15 results: Revenue up 16.73%; Buy for a target of 1950
Q4FY15 results: Revenue up 16.73%; Buy for a target of 1950Q4FY15 results: Revenue up 16.73%; Buy for a target of 1950
Q4FY15 results: Revenue up 16.73%; Buy for a target of 1950IndiaNotes.com
 
Firstcall man industries 21jul15
Firstcall man industries 21jul15Firstcall man industries 21jul15
Firstcall man industries 21jul15IndiaNotes.com
 
Irb infrastructure developers ltd q3 fy12 result update
Irb infrastructure developers ltd   q3 fy12 result updateIrb infrastructure developers ltd   q3 fy12 result update
Irb infrastructure developers ltd q3 fy12 result updateKeynote Capitals Ltd.
 
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoVidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoIndiaNotes.com
 
Buy D-Link (India) as rollout of 4G services drives demand for networking
Buy D-Link (India) as rollout of 4G services drives demand for networkingBuy D-Link (India) as rollout of 4G services drives demand for networking
Buy D-Link (India) as rollout of 4G services drives demand for networkingIndiaNotes.com
 
Indian coding and marking sector reaching maturity, Buy Control Print
Indian coding and marking sector reaching maturity, Buy Control PrintIndian coding and marking sector reaching maturity, Buy Control Print
Indian coding and marking sector reaching maturity, Buy Control PrintIndiaNotes.com
 
SKF India's net profit jumps to Rs512.40 mn during Q1CY15; Buy
SKF India's net profit jumps to Rs512.40 mn during Q1CY15; BuySKF India's net profit jumps to Rs512.40 mn during Q1CY15; Buy
SKF India's net profit jumps to Rs512.40 mn during Q1CY15; BuyIndiaNotes.com
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesIndiaNotes.com
 
Firstcall shilpi cable_technologies_ltd_8_july15
Firstcall shilpi cable_technologies_ltd_8_july15Firstcall shilpi cable_technologies_ltd_8_july15
Firstcall shilpi cable_technologies_ltd_8_july15IndiaNotes.com
 
Buy Abbott India; Pharma sector to grow at CAGR of 20% over next 5 years
Buy Abbott India; Pharma sector to grow at CAGR of 20% over next 5 yearsBuy Abbott India; Pharma sector to grow at CAGR of 20% over next 5 years
Buy Abbott India; Pharma sector to grow at CAGR of 20% over next 5 yearsIndiaNotes.com
 
Long term investment: Buy Bharat Forge for target price of Rs1220
Long term investment: Buy Bharat Forge for target price of Rs1220Long term investment: Buy Bharat Forge for target price of Rs1220
Long term investment: Buy Bharat Forge for target price of Rs1220IndiaNotes.com
 
PI Industries: Another strong performance; Sales up 16% in Q1FY15
 PI Industries: Another strong performance; Sales up 16% in Q1FY15 PI Industries: Another strong performance; Sales up 16% in Q1FY15
PI Industries: Another strong performance; Sales up 16% in Q1FY15IndiaNotes.com
 
Lmw ru2 qfy2011-261010
Lmw ru2 qfy2011-261010Lmw ru2 qfy2011-261010
Lmw ru2 qfy2011-261010Angel Broking
 
Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'
Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'
Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'IndiaNotes.com
 
Firstcall recommend PI Industries after Q4FY15 net profits rise 33.47% y/y
Firstcall recommend PI Industries after Q4FY15 net profits rise 33.47% y/yFirstcall recommend PI Industries after Q4FY15 net profits rise 33.47% y/y
Firstcall recommend PI Industries after Q4FY15 net profits rise 33.47% y/yIndiaNotes.com
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaIndiaNotes.com
 

What's hot (19)

Firstcall gillette 01jun15[1]
Firstcall gillette 01jun15[1]Firstcall gillette 01jun15[1]
Firstcall gillette 01jun15[1]
 
Medium-Long term investment: Buy NIIT for target price of 408
Medium-Long term investment: Buy NIIT for target price of 408Medium-Long term investment: Buy NIIT for target price of 408
Medium-Long term investment: Buy NIIT for target price of 408
 
Q4FY15 results: Revenue up 16.73%; Buy for a target of 1950
Q4FY15 results: Revenue up 16.73%; Buy for a target of 1950Q4FY15 results: Revenue up 16.73%; Buy for a target of 1950
Q4FY15 results: Revenue up 16.73%; Buy for a target of 1950
 
Firstcall man industries 21jul15
Firstcall man industries 21jul15Firstcall man industries 21jul15
Firstcall man industries 21jul15
 
Irb infrastructure developers ltd q3 fy12 result update
Irb infrastructure developers ltd   q3 fy12 result updateIrb infrastructure developers ltd   q3 fy12 result update
Irb infrastructure developers ltd q3 fy12 result update
 
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoVidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
 
Buy D-Link (India) as rollout of 4G services drives demand for networking
Buy D-Link (India) as rollout of 4G services drives demand for networkingBuy D-Link (India) as rollout of 4G services drives demand for networking
Buy D-Link (India) as rollout of 4G services drives demand for networking
 
Indian coding and marking sector reaching maturity, Buy Control Print
Indian coding and marking sector reaching maturity, Buy Control PrintIndian coding and marking sector reaching maturity, Buy Control Print
Indian coding and marking sector reaching maturity, Buy Control Print
 
SKF India's net profit jumps to Rs512.40 mn during Q1CY15; Buy
SKF India's net profit jumps to Rs512.40 mn during Q1CY15; BuySKF India's net profit jumps to Rs512.40 mn during Q1CY15; Buy
SKF India's net profit jumps to Rs512.40 mn during Q1CY15; Buy
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
 
Firstcall shilpi cable_technologies_ltd_8_july15
Firstcall shilpi cable_technologies_ltd_8_july15Firstcall shilpi cable_technologies_ltd_8_july15
Firstcall shilpi cable_technologies_ltd_8_july15
 
Buy Abbott India; Pharma sector to grow at CAGR of 20% over next 5 years
Buy Abbott India; Pharma sector to grow at CAGR of 20% over next 5 yearsBuy Abbott India; Pharma sector to grow at CAGR of 20% over next 5 years
Buy Abbott India; Pharma sector to grow at CAGR of 20% over next 5 years
 
korea airport service-005430-Algorithm Investment Report
korea airport service-005430-Algorithm Investment Reportkorea airport service-005430-Algorithm Investment Report
korea airport service-005430-Algorithm Investment Report
 
Long term investment: Buy Bharat Forge for target price of Rs1220
Long term investment: Buy Bharat Forge for target price of Rs1220Long term investment: Buy Bharat Forge for target price of Rs1220
Long term investment: Buy Bharat Forge for target price of Rs1220
 
PI Industries: Another strong performance; Sales up 16% in Q1FY15
 PI Industries: Another strong performance; Sales up 16% in Q1FY15 PI Industries: Another strong performance; Sales up 16% in Q1FY15
PI Industries: Another strong performance; Sales up 16% in Q1FY15
 
Lmw ru2 qfy2011-261010
Lmw ru2 qfy2011-261010Lmw ru2 qfy2011-261010
Lmw ru2 qfy2011-261010
 
Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'
Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'
Gabriel India: Q4FY15 net profit up 55.52% y/y to INR129.55m; 'Buy'
 
Firstcall recommend PI Industries after Q4FY15 net profits rise 33.47% y/y
Firstcall recommend PI Industries after Q4FY15 net profits rise 33.47% y/yFirstcall recommend PI Industries after Q4FY15 net profits rise 33.47% y/y
Firstcall recommend PI Industries after Q4FY15 net profits rise 33.47% y/y
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 

Similar to Skipper remains leading player in the transmission tower business

Ashok Leyland Q1FY15: Losses narrowed down to Rs48 mn, hold
 Ashok Leyland Q1FY15: Losses narrowed down to Rs48 mn, hold Ashok Leyland Q1FY15: Losses narrowed down to Rs48 mn, hold
Ashok Leyland Q1FY15: Losses narrowed down to Rs48 mn, holdIndiaNotes.com
 
Welspun Corp's net jumps to Rs163.80 mn in Q1FY16; Maintain buy
Welspun Corp's net jumps to Rs163.80 mn in Q1FY16; Maintain buyWelspun Corp's net jumps to Rs163.80 mn in Q1FY16; Maintain buy
Welspun Corp's net jumps to Rs163.80 mn in Q1FY16; Maintain buyIndiaNotes.com
 
Good Luck Steel Tubes Q4FY15: Net profit up 158.31% y/y; Buy
Good Luck Steel Tubes Q4FY15: Net profit up 158.31% y/y; BuyGood Luck Steel Tubes Q4FY15: Net profit up 158.31% y/y; Buy
Good Luck Steel Tubes Q4FY15: Net profit up 158.31% y/y; BuyIndiaNotes.com
 
Heidelberg Cement reports superlative set of numbers for Q1FY15; Hold
 Heidelberg Cement reports superlative set of numbers for Q1FY15; Hold Heidelberg Cement reports superlative set of numbers for Q1FY15; Hold
Heidelberg Cement reports superlative set of numbers for Q1FY15; HoldIndiaNotes.com
 
Firstcall irb infrastructure_developers_ltd_15_june15
Firstcall irb infrastructure_developers_ltd_15_june15Firstcall irb infrastructure_developers_ltd_15_june15
Firstcall irb infrastructure_developers_ltd_15_june15IndiaNotes.com
 
Atul Auto: Aims at Rs1000 cr turnover in the medium term
Atul Auto: Aims at Rs1000 cr turnover in the medium termAtul Auto: Aims at Rs1000 cr turnover in the medium term
Atul Auto: Aims at Rs1000 cr turnover in the medium termIndiaNotes.com
 
Lumax Industries quarterly results above estimates; buy
Lumax Industries quarterly results above estimates; buyLumax Industries quarterly results above estimates; buy
Lumax Industries quarterly results above estimates; buyIndiaNotes.com
 
Cyient 1QFY18
Cyient 1QFY18Cyient 1QFY18
Cyient 1QFY18Mohit Jn
 
Sunil Hitech Engineers bags major government contracts; Buy
Sunil Hitech Engineers bags major government contracts; BuySunil Hitech Engineers bags major government contracts; Buy
Sunil Hitech Engineers bags major government contracts; BuyIndiaNotes.com
 
Tata Sponge: Q1 Net grows a whopping 145.45%, buy
Tata Sponge: Q1 Net grows a whopping 145.45%, buyTata Sponge: Q1 Net grows a whopping 145.45%, buy
Tata Sponge: Q1 Net grows a whopping 145.45%, buyIndiaNotes.com
 
Setco Automotive Q1FY15: Revenue in-line; PAT below estimates - SPA Securities
Setco Automotive Q1FY15: Revenue in-line; PAT below estimates - SPA SecuritiesSetco Automotive Q1FY15: Revenue in-line; PAT below estimates - SPA Securities
Setco Automotive Q1FY15: Revenue in-line; PAT below estimates - SPA SecuritiesIndiaNotes.com
 
Nirmal bang gati_15may_2014[1]
Nirmal bang gati_15may_2014[1]Nirmal bang gati_15may_2014[1]
Nirmal bang gati_15may_2014[1]IndiaNotes.com
 
Website Final Press Conference
Website Final Press ConferenceWebsite Final Press Conference
Website Final Press ConferenceKristian Pura
 
Magna Electrocastings' PAT foreseen rising by CAGR of 8% over 2014 to 2017E, Buy
Magna Electrocastings' PAT foreseen rising by CAGR of 8% over 2014 to 2017E, BuyMagna Electrocastings' PAT foreseen rising by CAGR of 8% over 2014 to 2017E, Buy
Magna Electrocastings' PAT foreseen rising by CAGR of 8% over 2014 to 2017E, BuyIndiaNotes.com
 
ENIL 1QFY18
ENIL 1QFY18ENIL 1QFY18
ENIL 1QFY18Mohit Jn
 
JK Lakshmi Cement Q4FY15: Attractive valuations; Maintain buy
JK Lakshmi Cement Q4FY15: Attractive valuations; Maintain buyJK Lakshmi Cement Q4FY15: Attractive valuations; Maintain buy
JK Lakshmi Cement Q4FY15: Attractive valuations; Maintain buyIndiaNotes.com
 
Chembond Chemicals: To keep its growth story; Maintain buy
Chembond Chemicals: To keep its growth story; Maintain buyChembond Chemicals: To keep its growth story; Maintain buy
Chembond Chemicals: To keep its growth story; Maintain buyIndiaNotes.com
 

Similar to Skipper remains leading player in the transmission tower business (20)

Ashok Leyland Q1FY15: Losses narrowed down to Rs48 mn, hold
 Ashok Leyland Q1FY15: Losses narrowed down to Rs48 mn, hold Ashok Leyland Q1FY15: Losses narrowed down to Rs48 mn, hold
Ashok Leyland Q1FY15: Losses narrowed down to Rs48 mn, hold
 
Welspun Corp's net jumps to Rs163.80 mn in Q1FY16; Maintain buy
Welspun Corp's net jumps to Rs163.80 mn in Q1FY16; Maintain buyWelspun Corp's net jumps to Rs163.80 mn in Q1FY16; Maintain buy
Welspun Corp's net jumps to Rs163.80 mn in Q1FY16; Maintain buy
 
Good Luck Steel Tubes Q4FY15: Net profit up 158.31% y/y; Buy
Good Luck Steel Tubes Q4FY15: Net profit up 158.31% y/y; BuyGood Luck Steel Tubes Q4FY15: Net profit up 158.31% y/y; Buy
Good Luck Steel Tubes Q4FY15: Net profit up 158.31% y/y; Buy
 
Heidelberg Cement reports superlative set of numbers for Q1FY15; Hold
 Heidelberg Cement reports superlative set of numbers for Q1FY15; Hold Heidelberg Cement reports superlative set of numbers for Q1FY15; Hold
Heidelberg Cement reports superlative set of numbers for Q1FY15; Hold
 
Firstcall irb infrastructure_developers_ltd_15_june15
Firstcall irb infrastructure_developers_ltd_15_june15Firstcall irb infrastructure_developers_ltd_15_june15
Firstcall irb infrastructure_developers_ltd_15_june15
 
Atul Auto: Aims at Rs1000 cr turnover in the medium term
Atul Auto: Aims at Rs1000 cr turnover in the medium termAtul Auto: Aims at Rs1000 cr turnover in the medium term
Atul Auto: Aims at Rs1000 cr turnover in the medium term
 
Lumax Industries quarterly results above estimates; buy
Lumax Industries quarterly results above estimates; buyLumax Industries quarterly results above estimates; buy
Lumax Industries quarterly results above estimates; buy
 
Cyient 1QFY18
Cyient 1QFY18Cyient 1QFY18
Cyient 1QFY18
 
Sunil Hitech Engineers bags major government contracts; Buy
Sunil Hitech Engineers bags major government contracts; BuySunil Hitech Engineers bags major government contracts; Buy
Sunil Hitech Engineers bags major government contracts; Buy
 
Sample Financial Reports
Sample Financial ReportsSample Financial Reports
Sample Financial Reports
 
Tata Sponge: Q1 Net grows a whopping 145.45%, buy
Tata Sponge: Q1 Net grows a whopping 145.45%, buyTata Sponge: Q1 Net grows a whopping 145.45%, buy
Tata Sponge: Q1 Net grows a whopping 145.45%, buy
 
Setco Automotive Q1FY15: Revenue in-line; PAT below estimates - SPA Securities
Setco Automotive Q1FY15: Revenue in-line; PAT below estimates - SPA SecuritiesSetco Automotive Q1FY15: Revenue in-line; PAT below estimates - SPA Securities
Setco Automotive Q1FY15: Revenue in-line; PAT below estimates - SPA Securities
 
Nirmal bang gati_15may_2014[1]
Nirmal bang gati_15may_2014[1]Nirmal bang gati_15may_2014[1]
Nirmal bang gati_15may_2014[1]
 
Website Final Press Conference
Website Final Press ConferenceWebsite Final Press Conference
Website Final Press Conference
 
120981064 new-doll
120981064 new-doll120981064 new-doll
120981064 new-doll
 
Magna Electrocastings' PAT foreseen rising by CAGR of 8% over 2014 to 2017E, Buy
Magna Electrocastings' PAT foreseen rising by CAGR of 8% over 2014 to 2017E, BuyMagna Electrocastings' PAT foreseen rising by CAGR of 8% over 2014 to 2017E, Buy
Magna Electrocastings' PAT foreseen rising by CAGR of 8% over 2014 to 2017E, Buy
 
ENIL 1QFY18
ENIL 1QFY18ENIL 1QFY18
ENIL 1QFY18
 
JK Lakshmi Cement Q4FY15: Attractive valuations; Maintain buy
JK Lakshmi Cement Q4FY15: Attractive valuations; Maintain buyJK Lakshmi Cement Q4FY15: Attractive valuations; Maintain buy
JK Lakshmi Cement Q4FY15: Attractive valuations; Maintain buy
 
Chembond Chemicals: To keep its growth story; Maintain buy
Chembond Chemicals: To keep its growth story; Maintain buyChembond Chemicals: To keep its growth story; Maintain buy
Chembond Chemicals: To keep its growth story; Maintain buy
 
Transnet annual results 2015
Transnet annual results 2015Transnet annual results 2015
Transnet annual results 2015
 

More from IndiaNotes.com

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15IndiaNotes.com
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaIndiaNotes.com
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...IndiaNotes.com
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...IndiaNotes.com
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CAREIndiaNotes.com
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...IndiaNotes.com
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16EIndiaNotes.com
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...IndiaNotes.com
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyIndiaNotes.com
 
Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15IndiaNotes.com
 
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndiaNotes.com
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyIndiaNotes.com
 
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetTorrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetIndiaNotes.com
 
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...IndiaNotes.com
 
Agro Tech Foods: Demonstrates continued strong growth in tough environment; Buy
Agro Tech Foods: Demonstrates continued strong growth in tough environment; BuyAgro Tech Foods: Demonstrates continued strong growth in tough environment; Buy
Agro Tech Foods: Demonstrates continued strong growth in tough environment; BuyIndiaNotes.com
 
ATS Research positive on Deepak Nitrate, buy at CMP and further add on declines
ATS Research positive on Deepak Nitrate, buy at CMP and further add on declinesATS Research positive on Deepak Nitrate, buy at CMP and further add on declines
ATS Research positive on Deepak Nitrate, buy at CMP and further add on declinesIndiaNotes.com
 
Firstcall can fin_homes_ltd_29_july15
Firstcall can fin_homes_ltd_29_july15Firstcall can fin_homes_ltd_29_july15
Firstcall can fin_homes_ltd_29_july15IndiaNotes.com
 
Fce sqs india_29_jul15
Fce sqs india_29_jul15Fce sqs india_29_jul15
Fce sqs india_29_jul15IndiaNotes.com
 

More from IndiaNotes.com (20)

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARE
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16E
 
Nirmal lupin 06_aug15
Nirmal lupin 06_aug15Nirmal lupin 06_aug15
Nirmal lupin 06_aug15
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, Buy
 
Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15
 
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
 
Fce thermax 31_jul15
Fce thermax 31_jul15Fce thermax 31_jul15
Fce thermax 31_jul15
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
 
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price targetTorrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
Torrent Pharma Q1FY16: IndiaNivesh maintain 'buy' for an upgraded price target
 
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...
IndiaNivesh maintain 'buy' on this textile scrip with upgraded target after Q...
 
Agro Tech Foods: Demonstrates continued strong growth in tough environment; Buy
Agro Tech Foods: Demonstrates continued strong growth in tough environment; BuyAgro Tech Foods: Demonstrates continued strong growth in tough environment; Buy
Agro Tech Foods: Demonstrates continued strong growth in tough environment; Buy
 
ATS Research positive on Deepak Nitrate, buy at CMP and further add on declines
ATS Research positive on Deepak Nitrate, buy at CMP and further add on declinesATS Research positive on Deepak Nitrate, buy at CMP and further add on declines
ATS Research positive on Deepak Nitrate, buy at CMP and further add on declines
 
Firstcall can fin_homes_ltd_29_july15
Firstcall can fin_homes_ltd_29_july15Firstcall can fin_homes_ltd_29_july15
Firstcall can fin_homes_ltd_29_july15
 
Fce sqs india_29_jul15
Fce sqs india_29_jul15Fce sqs india_29_jul15
Fce sqs india_29_jul15
 

Recently uploaded

VIP Kolkata Call Girl Serampore 👉 8250192130 Available With Room
VIP Kolkata Call Girl Serampore 👉 8250192130  Available With RoomVIP Kolkata Call Girl Serampore 👉 8250192130  Available With Room
VIP Kolkata Call Girl Serampore 👉 8250192130 Available With Roomdivyansh0kumar0
 
BPPG response - Options for Defined Benefit schemes - 19Apr24.pdf
BPPG response - Options for Defined Benefit schemes - 19Apr24.pdfBPPG response - Options for Defined Benefit schemes - 19Apr24.pdf
BPPG response - Options for Defined Benefit schemes - 19Apr24.pdfHenry Tapper
 
Stock Market Brief Deck for 4/24/24 .pdf
Stock Market Brief Deck for 4/24/24 .pdfStock Market Brief Deck for 4/24/24 .pdf
Stock Market Brief Deck for 4/24/24 .pdfMichael Silva
 
Classical Theory of Macroeconomics by Adam Smith
Classical Theory of Macroeconomics by Adam SmithClassical Theory of Macroeconomics by Adam Smith
Classical Theory of Macroeconomics by Adam SmithAdamYassin2
 
Governor Olli Rehn: Dialling back monetary restraint
Governor Olli Rehn: Dialling back monetary restraintGovernor Olli Rehn: Dialling back monetary restraint
Governor Olli Rehn: Dialling back monetary restraintSuomen Pankki
 
Call Girls Near Me WhatsApp:+91-9833363713
Call Girls Near Me WhatsApp:+91-9833363713Call Girls Near Me WhatsApp:+91-9833363713
Call Girls Near Me WhatsApp:+91-9833363713Sonam Pathan
 
AfRESFullPaper22018EmpiricalPerformanceofRealEstateInvestmentTrustsandShareho...
AfRESFullPaper22018EmpiricalPerformanceofRealEstateInvestmentTrustsandShareho...AfRESFullPaper22018EmpiricalPerformanceofRealEstateInvestmentTrustsandShareho...
AfRESFullPaper22018EmpiricalPerformanceofRealEstateInvestmentTrustsandShareho...yordanosyohannes2
 
(办理学位证)加拿大萨省大学毕业证成绩单原版一比一
(办理学位证)加拿大萨省大学毕业证成绩单原版一比一(办理学位证)加拿大萨省大学毕业证成绩单原版一比一
(办理学位证)加拿大萨省大学毕业证成绩单原版一比一S SDS
 
Call Girls In Yusuf Sarai Women Seeking Men 9654467111
Call Girls In Yusuf Sarai Women Seeking Men 9654467111Call Girls In Yusuf Sarai Women Seeking Men 9654467111
Call Girls In Yusuf Sarai Women Seeking Men 9654467111Sapana Sha
 
House of Commons ; CDC schemes overview document
House of Commons ; CDC schemes overview documentHouse of Commons ; CDC schemes overview document
House of Commons ; CDC schemes overview documentHenry Tapper
 
VIP Kolkata Call Girl Jodhpur Park 👉 8250192130 Available With Room
VIP Kolkata Call Girl Jodhpur Park 👉 8250192130  Available With RoomVIP Kolkata Call Girl Jodhpur Park 👉 8250192130  Available With Room
VIP Kolkata Call Girl Jodhpur Park 👉 8250192130 Available With Roomdivyansh0kumar0
 
(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办
(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办
(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办fqiuho152
 
20240417-Calibre-April-2024-Investor-Presentation.pdf
20240417-Calibre-April-2024-Investor-Presentation.pdf20240417-Calibre-April-2024-Investor-Presentation.pdf
20240417-Calibre-April-2024-Investor-Presentation.pdfAdnet Communications
 
chapter_2.ppt The labour market definitions and trends
chapter_2.ppt The labour market definitions and trendschapter_2.ppt The labour market definitions and trends
chapter_2.ppt The labour market definitions and trendslemlemtesfaye192
 
Authentic No 1 Amil Baba In Pakistan Authentic No 1 Amil Baba In Karachi No 1...
Authentic No 1 Amil Baba In Pakistan Authentic No 1 Amil Baba In Karachi No 1...Authentic No 1 Amil Baba In Pakistan Authentic No 1 Amil Baba In Karachi No 1...
Authentic No 1 Amil Baba In Pakistan Authentic No 1 Amil Baba In Karachi No 1...First NO1 World Amil baba in Faisalabad
 
原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证
原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证
原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证rjrjkk
 
letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...
letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...
letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...Henry Tapper
 
Andheri Call Girls In 9825968104 Mumbai Hot Models
Andheri Call Girls In 9825968104 Mumbai Hot ModelsAndheri Call Girls In 9825968104 Mumbai Hot Models
Andheri Call Girls In 9825968104 Mumbai Hot Modelshematsharma006
 
Interimreport1 January–31 March2024 Elo Mutual Pension Insurance Company
Interimreport1 January–31 March2024 Elo Mutual Pension Insurance CompanyInterimreport1 January–31 March2024 Elo Mutual Pension Insurance Company
Interimreport1 January–31 March2024 Elo Mutual Pension Insurance CompanyTyöeläkeyhtiö Elo
 

Recently uploaded (20)

Monthly Economic Monitoring of Ukraine No 231, April 2024
Monthly Economic Monitoring of Ukraine No 231, April 2024Monthly Economic Monitoring of Ukraine No 231, April 2024
Monthly Economic Monitoring of Ukraine No 231, April 2024
 
VIP Kolkata Call Girl Serampore 👉 8250192130 Available With Room
VIP Kolkata Call Girl Serampore 👉 8250192130  Available With RoomVIP Kolkata Call Girl Serampore 👉 8250192130  Available With Room
VIP Kolkata Call Girl Serampore 👉 8250192130 Available With Room
 
BPPG response - Options for Defined Benefit schemes - 19Apr24.pdf
BPPG response - Options for Defined Benefit schemes - 19Apr24.pdfBPPG response - Options for Defined Benefit schemes - 19Apr24.pdf
BPPG response - Options for Defined Benefit schemes - 19Apr24.pdf
 
Stock Market Brief Deck for 4/24/24 .pdf
Stock Market Brief Deck for 4/24/24 .pdfStock Market Brief Deck for 4/24/24 .pdf
Stock Market Brief Deck for 4/24/24 .pdf
 
Classical Theory of Macroeconomics by Adam Smith
Classical Theory of Macroeconomics by Adam SmithClassical Theory of Macroeconomics by Adam Smith
Classical Theory of Macroeconomics by Adam Smith
 
Governor Olli Rehn: Dialling back monetary restraint
Governor Olli Rehn: Dialling back monetary restraintGovernor Olli Rehn: Dialling back monetary restraint
Governor Olli Rehn: Dialling back monetary restraint
 
Call Girls Near Me WhatsApp:+91-9833363713
Call Girls Near Me WhatsApp:+91-9833363713Call Girls Near Me WhatsApp:+91-9833363713
Call Girls Near Me WhatsApp:+91-9833363713
 
AfRESFullPaper22018EmpiricalPerformanceofRealEstateInvestmentTrustsandShareho...
AfRESFullPaper22018EmpiricalPerformanceofRealEstateInvestmentTrustsandShareho...AfRESFullPaper22018EmpiricalPerformanceofRealEstateInvestmentTrustsandShareho...
AfRESFullPaper22018EmpiricalPerformanceofRealEstateInvestmentTrustsandShareho...
 
(办理学位证)加拿大萨省大学毕业证成绩单原版一比一
(办理学位证)加拿大萨省大学毕业证成绩单原版一比一(办理学位证)加拿大萨省大学毕业证成绩单原版一比一
(办理学位证)加拿大萨省大学毕业证成绩单原版一比一
 
Call Girls In Yusuf Sarai Women Seeking Men 9654467111
Call Girls In Yusuf Sarai Women Seeking Men 9654467111Call Girls In Yusuf Sarai Women Seeking Men 9654467111
Call Girls In Yusuf Sarai Women Seeking Men 9654467111
 
House of Commons ; CDC schemes overview document
House of Commons ; CDC schemes overview documentHouse of Commons ; CDC schemes overview document
House of Commons ; CDC schemes overview document
 
VIP Kolkata Call Girl Jodhpur Park 👉 8250192130 Available With Room
VIP Kolkata Call Girl Jodhpur Park 👉 8250192130  Available With RoomVIP Kolkata Call Girl Jodhpur Park 👉 8250192130  Available With Room
VIP Kolkata Call Girl Jodhpur Park 👉 8250192130 Available With Room
 
(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办
(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办
(办理原版一样)QUT毕业证昆士兰科技大学毕业证学位证留信学历认证成绩单补办
 
20240417-Calibre-April-2024-Investor-Presentation.pdf
20240417-Calibre-April-2024-Investor-Presentation.pdf20240417-Calibre-April-2024-Investor-Presentation.pdf
20240417-Calibre-April-2024-Investor-Presentation.pdf
 
chapter_2.ppt The labour market definitions and trends
chapter_2.ppt The labour market definitions and trendschapter_2.ppt The labour market definitions and trends
chapter_2.ppt The labour market definitions and trends
 
Authentic No 1 Amil Baba In Pakistan Authentic No 1 Amil Baba In Karachi No 1...
Authentic No 1 Amil Baba In Pakistan Authentic No 1 Amil Baba In Karachi No 1...Authentic No 1 Amil Baba In Pakistan Authentic No 1 Amil Baba In Karachi No 1...
Authentic No 1 Amil Baba In Pakistan Authentic No 1 Amil Baba In Karachi No 1...
 
原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证
原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证
原版1:1复刻温哥华岛大学毕业证Vancouver毕业证留信学历认证
 
letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...
letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...
letter-from-the-chair-to-the-fca-relating-to-british-steel-pensions-scheme-15...
 
Andheri Call Girls In 9825968104 Mumbai Hot Models
Andheri Call Girls In 9825968104 Mumbai Hot ModelsAndheri Call Girls In 9825968104 Mumbai Hot Models
Andheri Call Girls In 9825968104 Mumbai Hot Models
 
Interimreport1 January–31 March2024 Elo Mutual Pension Insurance Company
Interimreport1 January–31 March2024 Elo Mutual Pension Insurance CompanyInterimreport1 January–31 March2024 Elo Mutual Pension Insurance Company
Interimreport1 January–31 March2024 Elo Mutual Pension Insurance Company
 

Skipper remains leading player in the transmission tower business

  • 1. 1 Transmission & Distribution Skipper Ltd. Sensex: 26425 CMP:INR153 Leading player in the transmission tower business Skipper is among the top 3 players in the transmission tower business (after KEC Intl and Kalpataru) with a capacity of 175000 MTPA (25000 added in H1CY15). The company operates in 400 KV - 1200 KV segment, which has entry barriers like pre- qualification, quality & infrastructure related criteria, and derives 85% of revenue from Powergrid projects. 54% of India's transmission line network is expected to be in 400 KV and above by the end of 12th Plan. Presence across transmission business sub-segments The transmission business also consist of poles-monopoles segment and galvanising facilities. Monopoles find their application in telecom towers and replacement of lattice towers in urban areas. Telecom companies, PGCIL and SEBs are now prefering use of monopoles for their urban and semi-urban regions. The company also has galvanising capacity of ~150000 MTPA for galvanising towers and poles. Skipper is planning to further expand the galvanising capacity by 50000 MTPA. 10x increase in PVC pipes capacity Skipper plans to increase the PVC pipe (7% of revenue) capacity by 10x to 100000 MTPA by FY18 of which 30000 MTPA is likely to start in FY16 (10000 each in Ahmedabad, Secunderabad and Guwahati; Ahmedabad facility started). Multi-locational manufacturing facilities will help in saving freight costs and aid margin expansion. With multifold increase in capacity and decent profit margin, we expect PVC division to contribute significantly to the overall revenue & profits. To increase the share of revenue from plumbing sector, the company has partnered with global leaders like Sekisui Chemicals (Japan) and Wavin group (Netherlands) for CPVC and fittings respectively. Currently agri June 15, 2015 VISITNOTE sector account for 75% of revenue, which the company is planning toreduceto60%inthecomingquarters.Thecompanyhasamarket share of ~10% in Eastern India. Integrated Business model Skipper claims to be the only integrated player of its size in India. Angle rolling, which is the main raw material for towers, is manufactured inhouse (capacity- 180000 MTPA). Skipper also enjoys the locational advantage of being situated in Eastern India where all the primary steel plants are located, thereby saving logistics cost for the company on raw materials. Skipper has also done forward integration and now participates in EPC projects. Capex plans & Debt outlook The company plans to incur capex of INR 350 mn in FY16 of which INR 200 mn will be invested in PVC pipe division capex and INR 150 mn for transmission business. The company has total outstanding debt of ~INR 4 bn including CC of INR 2 bn. Given its sizeable capex requirements over the medium term, we don't expect significant reduction in debt going forward. Order book The company has order book of ~INR 24 bn (Book to bill ratio of 1.83x) of which 45% is from overseas and rest is domestic. Most of the export orders are from LATAM. Outlook and Valuation The Power ministry plans to attract investments worth INR 4000 bn in the T&D space over the next 4 years. Creation of smart cities, focus on improving irrigation facilities, rapid urbanisation and improvement in urban infrastructure are likely to create demand for water transportation pipes. Skipper ltd. is gearing up to cash in ontheemergingopportunitieswithaggressivecapexandincreasing distribution reach (coupled with brand led marketing). Topline & bottomlinegrewataCAGRof20.8%and118.3%respectivelybetween FY13-15. At CMP, the stock is trading at 17.5x FY15 earnings. Shareholding (%) Mar-15 Promoters 72.38 FIIs 0.16 DIIs 0.00 Others 27.46 Relative Price Performance Key Data BSE Code 538562 NSE Code SKIPPER Bloomberg Code SKIPPER IN Shares Outstanding (mn) 102.32 Face Value 1 Mcap (INR bn) 16.16 52 Week H/L 200.00/32.00 2W Avg. Qty.NSE 5533 Free Float (INR Bn) 4.46 Beta 1.21 (INR mn) FY12 FY13 FY14 FY15 Net Sales 7629 9282 10731 13128 Growth 47.20% 21.67% 15.61% 22.34% EBIDTAM (%) 8.17 9.73 11.01 16.39 Adj. PAT 98 187 269 892 Growth -40.33% 91.51% 43.67% 231.36% Adj. EPS (INR) 0.96 1.81 2.6 8.72 P/E(x) NA NA NA 17.55 EV/EBIDTA NA NA NA 8.86 Net Debt/Equity 1.78 2 1.79 1.08 RoACE (%) 10.7 14.56 16.24 17.52 RoAE (%) 5.94 11.24 12.53 27.88 At our recent interaction with the management of Skipper limited, they sounded positive on the road ahead on the back of significant emerging opportunities in the power transmission tower sector and PVC pipes industry. Skipper limited, promoted by Kolkata based Bansal group, is engaged in manufacturing of towers (power transmission and telecom), PVC pipes & fittings, poles & monopoles, etc. Transmission segment, PVC pipes segment and Infrastructure segment account for 89%, 7% and 4% of revenues respectively. The company aspires to grow in Power T&D business by 3x and Water business by 10x. Given below are the key takeaways from the visit- Prashant Biyani prashant.biyani@spagroupindia.com Ph. No. 91 33 4011 4800 (Ext. 833) 0 100 200 300 400 500 600 Jul-14 Aug-14 Sep-14 Oct-14 Nov-14 Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Skipper Sensex
  • 2. 2 Transmission & Distribution Quarterly Financials Particulars (INR Mn) Q4FY15 Q3FY15 QoQ Q2FY15 Q1FY15 Q4FY14 YoY Gross Sales 5601 3537 58.37% 3378 2056 4730 18.44% Excise Duty 602 309 94.57% 309 224 416 44.57% Net Sales 4999 3227 54.90% 3069 1832 4313 15.91% Other Income 1 7 -88.41% 1 8 9 -90.91% Total Income 5000 3234 54.60% 3070 1840 4322 15.69% Raw Material Consumed 2489 2508 -0.75% 1853 1700 2778 -10.39% Stock Adjustment 1128 (276) NA (71) (535) 715 57.84% Employee Expenses 87 93 -6.24% 89 71 70 24.04% Other Expenses 608 427 42.28% 481 321 373 62.99% TOTAL EXPENDITURE 4313 2753 56.64% 2352 1558 3936 9.57% EBITDA 687 474 44.85% 717 274 377 82.10% Depreciation 63 52 22.63% 51 54 38 67.72% EBIT 624 422 47.57% 666 220 339 83.71% Interest 154 173 -11.37% 129 127 201 -23.70% PBT 471 256 83.80% 538 101 147 220.42% Tax 168 86 96.73% 185 35 39 333.51% PAT 303 171 77.32% 353 65 108 179.83% Equity 102 102 0.00% 102 102 102 0.00% Face Value 1 1 0.00% 1 1 1 0.00% EPS 2.96 1.67 77.32% 3.45 0.64 1.06 179.83% EBITDAM 13.74% 14.69% (95 bps) 23.35% 14.95% 8.75% 499 bps OPM 13.76% 14.91% (115 bps) 23.38% 15.38% 8.95% 481 bps PATM 6.05% 5.29% 76 bps 11.50% 3.57% 2.51% 354 bps Segmental Quarterly Financials Particulars (INR Mn) Q4FY15 Q3FY15 QoQ Q2FY15 Q1FY15 Q4FY15 YoY REVENUES Infrastructure Projects 152 141 8.09% 110 59 162 -6.16% PVC Pipe 434 187 131.45% 93 184 273 58.85% Engineering Products 4413 2899 52.23% 2446 1589 3878 13.81% Profit/Loss Before Interest and Tax Infrastructure Projects 13 53 -76.33% 28 16 79 -84.24% PVC Pipe 55 19 195.72% 18 11 21 160.85% Engineering Products 970 390 148.55% 233 217 273 255.69% CAPITAL EMPLOYED Infrastructure Projects 189 196 -3.47% 205 186 163 16.14% PVC Pipe 459 301 52.22% 294 297 334 37.40% Engineering Products 6218 7289 -14.70% 7179 5827 5836 6.53%
  • 3. 3 Transmission & Distribution Financials Income statement Year End March (INR mn) FY12 FY13 FY14 FY15 Net Sales 7629 9282 10731 13128 Growth 47.20% 21.67% 15.61% 22.34% Cost of Goods Sold 5582 6829 7601 8797 Employee Cost 154 173 242 341 Other Optg. Exps. 1270 1377 1707 1838 Total Optg. Exps. 7006 8378 9549 10976 EBIDTA (excl OI) 623 903 1182 2152 Growth 26.99% 45.03% 30.81% 82.08% EBITDA Margin 8.17% 9.73% 11.01% 16.39% Dep./Amortization 117 126 151 220 EBIT 506 778 1031 1932 EBIT Margin 6.63% 8.38% 9.61% 14.71% Interest Expense 368 514 685 583 Other Income 8 14 21 17 EBT 146 278 367 1366 Tax Expenses 47 91 98 474 PAT 99 187 269 892 Adjustment to PAT 1 (0) 0 0 APAT 98 187 269 892 Growth -40.33% 91.51% 43.67% 231.36% APAT Margin 1.28% 2.02% 2.51% 6.79% Balance Sheet Year End March (INR mn) FY12 FY13 FY14 FY15 Share Capital 360 97 102 102 Reserves and Surplus 1275 1964 2209 3096 Total Networth 1635 2061 2312 3199 Total Debt 2994 4243 4395 4000 Deferred Tax Liability 111 181 218 265 Other Liabilities 7 16 10 0 Sources of Funds 4709 6462 6896 7463 Net Block 2809 3259 3430 3547 Investments 0 0 0 0 Current Assets 3839 4562 5326 7059 Current Liabilities 1946 1368 1881 3173 Net Current Assets 1892 3194 3445 3886 Other Assets 7 9 21 30 Application of Funds 4709 6462 6896 7463 Cash Flow Year End March (INR mn) FY12 FY13 FY14 FY15 EBT 146 278 367 1366 Less: Other Income/Exceptionals (8) (14) (21) (17) Add:Depreciation 117 126 151 220 Add: Interest paid 368 514 685 583 Direct taxes paid (29) (56) (77) (474) Change in Working Capital 846 (1260) (116) (589) Others 16 28 43 0 Cash Flow from operations (a) 1456 (383) 1032 1089 Change in Fixed Assets (548) (574) (315) (118) Change in Investments 0 0 0 0 Cash Flow from Investing (b) (548) (574) (315) (118) Change in Equity 0 540 0 0 Debt Raised/(Repaid) (477) 1249 152 (395) Interest paid (368) (514) (685) (583) Others (7) (10) (15) 422 Cash Flow from Financing (c ) (852) 1265 (549) (673) Net Change in Cash (a+b+c) 57 308 168 298 Opening Cash 69 86 128 263 Closing Cash 86 128 263 561 Key Ratios Year End March FY12 FY13 FY14 FY15 Per Share Data (INR) Reported EPS 1.40 1.92 2.63 8.72 Adj. EPS 1.34 1.83 2.63 8.72 Growth -43.93% 36.57% 43.72% 231.43% CEPS 2.92 3.06 4.10 10.87 DPS 0.09 0.09 0.15 1.30 BVPS 17.66 19.76 22.22 31.27 Return Ratios (%) RoACE 10.70 14.56 16.24 17.52 RoANW 5.94 11.24 12.53 27.88 Liquidity Ratios Net Debt/Equity 1.78 2.00 1.79 1.08 Interest Coverage Ratio 1.40 1.54 1.54 0.30 Current Ratio 1.97 3.34 2.83 2.22 Efficiency Ratios Asset Turnover Ratio 1.62 1.44 1.56 1.76 Inventory Days 75 103 108 98 Debtor Days 64 56 73 84 Creditor Days 50 61 66 83 Valuation Ratios P/E(x) NA NA NA 17.55 P/BV (x) NA NA NA 4.89 P/CEPS (x) NA NA NA 14.08 Dividend Yield (%) NA NA NA 0.85 EV/Net Sales (x) NA NA NA 1.45 EV/EBIDTA(x) NA NA NA 8.86
  • 4. 4 Transmission & Distribution For More Information Visit Us At : www.spasecurities.com Sharad Avasthi Head - Equity Research sharad.avasthi@spagroupindia.com Tel.: +91-33-4011 4800 Ext.832 SPA Securities Ltd: Mittal Court, A-Wing, 10th Floor, Nariman Point, Mumbai - 400 021, Tel. No. : +91-022-4289 5600, Fax: +91 (22) 2657 3708/9 Analyst Certification of Independence: The analyst(s) for this report certifies that all the views expressed in this report accurately reflect his or her personal views about the subject company(ies) or issuers and no part of his or hercompensationwas,isorwillbe,directlyorindirectlyrelatedtospecificrecommendationsorviewsexpressedinthisreport.Theresearchanalystsareboundbystringentinternalregulationsandalsolegalandstatutoryrequirements of the Securities and Exchange Board of India (hereinafter "SEBI") and the analysts' compensation are completely delinked from all the other companies and/or entities of SPASecurities Limited, and have no bearing whatsoever on anyrecommendationthattheyhavegivenintheResearchReport. DisclaimerandDisclosuresasrequiredunderSEBI(Research Analyst)Regulations,2014:SPASecuritiesLimited(hereinafterreferasSPASecurities)anditsaffiliatesareengagedininvestmentbanking,investment advisory, stock broking, institutional equities, Mutual Fund Distributor and insurance broking. SPASecurities is a SEBI registered securities broking Company having membership of NSE, BSE & MCX for Equity, Future & Option, Currency Derivatives segment and Wholesale Debt Market. The Company is focused primarily on providing securities broking services to institutional clients and is empanelled as an approved securities broker with all the major Nationalised, PrivateandCo-operativebanks,Corporatehouses,InsuranceCompanies,FinancialInstitutions,AssetManagementCompaniesandProvidentFundTrusts.Detailsofaffiliatesareavailableonourwebsitei.e.www.spasecurities.com. Weherebydeclarethatouractivitieswereneithersuspendednorwehavedefaultedwithanystockexchangeauthoritywithwhom weareregisteredinthelastfiveyears.WehavenotbeendebarredfromdoingbusinessbyanyStock Exchange/SEBI or any other authorities, nor has our certificate of registration been cancelled by SEBI at any point of time. GeneralDisclosures: ThisResearchReport(hereinaftercalled"report")hasbeenpreparedbySPASecuritiesandismeantforsoleusebytherecipientandnotforcirculation.ThisReportdoesnotconstituteapersonalrecommendation or take into account the particular investment objectives, financial situations, or needs of individual clients. The recommendations, if any, made herein are expression of views and/or opinions and should not be deemed or construed tobeneitheradviceforthepurposeofpurchaseorsaleofanysecurity,(asdefinedundersection2(h)ofsecuritiesContracts(Regulation)Act.1956,throughSPASecuritiesnoranysolicitationorofferingofanyinvestment/tradingopportunity onbehalfoftheissuer(s)oftherespectivesecurity(ies)referredtoherein.RecipientsofthisReportshouldrelyoninformation/dataarisingoutoftheirowninvestigations.Readersareadvisedtoseekindependentprofessionaladvice and arrive at an informed trading/investment decision before executing any trades or making any investments. ThisReporthasbeenpreparedonthebasisofpubliclyavailableinformation,internallydevelopeddataandothersourcesbelievedbySPASecuritiestobereliable,althoughitsaccuracyandcompletenesscannotbeguaranteed.Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness.Any review, retransmission or any other use is prohibited. The information, opinions, views expressed in this Research Report are those of the research analyst as at the date of this Research Report which are subject to change and do not represent to be an authority on the subject. While we would endeavour to update the information herein on a reasonable basis, we are under no obligation to update the information.Also, there may be regulatory, compliance or other reasons that prevent us from doing so. Hence all such information and opinions are subject to change without notice. Our salespeople, traders, and other professionals may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that may be inconsistent with the recommendations expressed herein. This Research Report should be read and relied upon at the sole discretion and risk of the recipient. If you are dissatisfied with the contents of this complimentary Research Report or with the terms of this Disclaimer, your sole and exclusive remedy is to stop using this Research Report. Neither SPASecurities nor its affiliates or their respective directors, employees, agents or representatives shall be responsible or liable in any manner, directly or indirectly, for the losses or the damages sustained due to the investments made or any action taken on basis of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the dividend or income, etc. Compensation of our ResearchAnalysts is not based on any specific merchant banking, investment banking or brokerage service transactions. SPASecurities may have issued other reports in the past that are inconsistent with and reachdifferentconclusionfromtheinformationpresentedinthisreport. SPASecurities, its affiliates and employees may, from time to time, effect or have effected an own account transaction in, or deal as principal or agent in or for the securities mentioned in this document.They may perform or seek to perform investment banking or other services for, or solicit investment banking or other business from, any company referred to in this report. TheusershouldconsulttheirownadvisorstodeterminethemeritsandrisksofinvestmentandalsoreadtheRiskDisclosureDocumentsforCapitalMarketsandDerivativeSegmentsasprescribedbySecuritiesandExchangeBoard of India before investing in the Indian Markets. A graph of daily closing prices of securities is available at www.nseindia.com and http://economictimes.indiatimes.com/markets/stocks/stock-quotes. (Choose a company from the list on the browser and select the "three years" icon in the price chart). SPASecurities plans to register itself as a Research Entity under the SEBI (ResearchAnalysts) Regulations, 2014. Disclaimers in respect of jurisdiction: This report is not directed to, or intended for distribution to or use by, any person or entity who is a citizen or resident or located in any locality, state, country or other jurisdiction where such distribution, publication, reproduction, availability or use would be contrary to law or regulation or what would subject SPASecurities or its affiliates to any registration or licensing requirement within such jurisdiction. If this report is inadvertentlysendorhasreachedanyindividualinsuchcountry,especially,USA,thesamemaybeignoredandbroughttotheattentionofthesender.Thisdocumentmaynotbereproduced,distributedorpublishedforanypurposes without prior written approval of SPASecurities. List of Associates as per SEBI (Research Analyst) Regulations, 2014 • SPAInsurance Broking Services limited Statements on ownership and material conflicts of interest, compensation - SPA and Associates Disclosure of interest statement Yes/No SPA Securities/its Affiliates/Analyst/his or her Relative financial interest in the company No SPA Securities/its Affiliates/Analyst/his or her Relative actual/beneficial ownership of more than 1% in subject company at the end of the month Immediately preceding the date of the publication of the research report or date of public appearance. No Investment banking relationship with the company covered No Any other material conflict of interest at the time of publishing the research report No Receipt of compensation by SPA Securities or its Affiliated Companies from the subject company covered for in the last twelve months: • Managing/co-managing public offering of securities • Investmentbanking/merchantbanking/brokerageservices • products or services other than those above • in connection with research report No Whether Research Analyst has served as an officer, director or employee of the subject company covered No Whether the Research Analyst or Research Entity has been engaged in market making activity of the Subject Company; No For statements on ownership and material conflicts of interest, compensation, etc. for individual Research Analyst(s), please refer to each specific research report. SPA CAPITAL SERVICES LIMITED Investment Advisory Services, AMFI Reg. No. ARN-0007 SPA CAPITAL ADVISORS LIMITED SEBI registered Category-1 Merchant Bankers SEBI Regn. No. INM000010825 SPA COMTRADE PRIVATE LIMITED Member of NCDEX & MCX. NCDEX TMID-00729, NCDEXFMCNo.NCDEX/TCM/CORP/0714 SPAINSURANCE BROKING SERVICES LTD Direct Broker for Life and General Insurance Broking IRDA Lic. Code No. DB053/03 SPA Securities Ltd SEBI Reg. Nos. NSE Cash INB231178238 NSE Future & Option INF231173238 NSE Currency Derivatives INE231178238 BSE Cash INB011178234 BSE Currency Derivatives INE011178234 MCX-SX Cash INB261178231 MCX-SX Future & Option INF261178231 MCX-SX Currency Derivatives INE261178238 Mutual Fund ARN 77388 CDSLDP IN-DP-CDSL-485-2008 NSDLDP IN-DP-NSDL-316-2009